All News

AAO-HNS Continues Advocacy on Hypoglossal Nerve Stimulation Coverage for Treatment of Obstructive Sleep Apnea (7/20/20)

AAO-HNS Continues Advocacy on Hypoglossal Nerve Stimulation Coverage for Treatment of Obstructive Sleep Apnea (7/20/20)
AAO-HNS Continues Advocacy on Hypoglossal Nerve Stimulation Coverage for Treatment of Obstructive Sleep Apnea (7/20/20)

April 21, 2021

On July 20, the AAO-HNS sent comments to Anthem opposing their medical policy designating hypoglossal nerve stimulation (HGNS) as experimental / investigational for the treatment of obstructive sleep apnea. The Academy requested Anthem revisit and amend its policy given the strong evidence supporting HGNS as efficacious in improving outcomes in patients with OSA.

Related Content

AAO-HNS Opposition Leads to Positive Update on United Healthcare’s Rhinoplasty and Nasal Procedures Policy

Private Payer Advocacy

Following advocacy efforts by the AAO-HNS and the American Academy for Facial Plastic and Reconstructive Surgery (AAFPRS), on June…

AAO-HNS Comments on UHC Changes to Rhinoplasty and Other Nasal Surgeries Policy

Private Payer Advocacy

On January 27, the Academy sent comments to United Healthcare (UHC) regarding revisions made to the coverage criteria in…

AAO-HNS Advocates for Immediate Change to Horizon’s Modifier 25 Policy

Advocacy, Private Payer Advocacy

Effective August 1, 2022, Horizon Blue Cross Blue Shield will reimburse E/M services appended with Modifier 25 at 50% if a…

No External Use or Transfer (Including AI-Based Technologies): The materials and content on this website are provided for personal, non-commercial transitory viewing only. You are prohibited from copying or transferring any materials or content accessed through this website into applications, software, bots, or websites which may allow third parties to retain or use the content, including but not limited to those using artificial intelligence-based technologies or infrastructure. Please see the Terms of Use for more information.